Literature DB >> 24379208

Cytomegalovirus mutants resistant to ganciclovir and cidofovir differ in susceptibilities to synguanol and its 6-ether and 6-thioether derivatives.

Sunwen Chou1, Gloria Komazin-Meredith, John D Williams, Terry L Bowlin.   

Abstract

The methylenecyclopropane nucleoside (MCPN) analogs synguanol and its 6-alkoxy (MBX2168) and 6-alkylthio (MBX1616) derivatives retained good in vitro activities against several common ganciclovir-resistant UL97 kinase variants of human cytomegalovirus. Foscarnet-MCPN cross-resistance was observed among UL54 polymerase variants. UL54 exonuclease domain ganciclovir-cidofovir dual-resistant variants were remarkably more hypersensitive to these MCPNs than to cyclopropavir, with some 50% effective concentration ratios that were <0.1× the wild type. Different categories of MCPNs may have therapeutically exploitable mechanistic differences in viral DNA polymerase inhibition.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24379208      PMCID: PMC3957852          DOI: 10.1128/AAC.02544-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus.

Authors:  Sunwen Chou; Nell S Lurain; Kenneth D Thompson; Richard C Miner; W Lawrence Drew
Journal:  J Infect Dis       Date:  2003-06-16       Impact factor: 5.226

2.  Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene.

Authors:  Sunwen Chou; Laura C Van Wechel; Heather M Lichy; Gail I Marousek
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

3.  The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved.

Authors:  C W Knopf
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

4.  Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol) are active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants.

Authors:  Fausto Baldanti; Antonella Sarasini; John C Drach; Jiri Zemlicka; Giuseppe Gerna
Journal:  Antiviral Res       Date:  2002-12       Impact factor: 5.970

5.  Effective treatment of murine cytomegalovirus infections with methylenecyclopropane analogues of nucleosides.

Authors:  R J Rybak; J Zemlicka; Y L Qiu; C B Hartline; E R Kern
Journal:  Antiviral Res       Date:  1999-10       Impact factor: 5.970

6.  Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections.

Authors:  Earl R Kern; Deborah J Bidanset; Caroll B Hartline; Zhaohua Yan; Jiri Zemlicka; Debra C Quenelle
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

7.  A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.

Authors:  T Cihlar; M D Fuller; A S Mulato; J M Cherrington
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

8.  Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.

Authors:  T Cihlar; M D Fuller; J M Cherrington
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides.

Authors:  Shaoman Zhou; Julie M Breitenbach; Katherine Z Borysko; John C Drach; Earl R Kern; Elizabeth Gullen; Yung-Chi Cheng; Jiri Zemlicka
Journal:  J Med Chem       Date:  2004-01-29       Impact factor: 7.446

10.  Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions.

Authors:  Gloria Komazin-Meredith; Sunwen Chou; Mark N Prichard; Caroll B Hartline; Steven C Cardinale; Katelyn Comeau; John D Williams; Atiyya R Khan; Norton P Peet; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

View more
  5 in total

Review 1.  Current and potential treatments for ubiquitous but neglected herpesvirus infections.

Authors:  Jonathan E Gable; Timothy M Acker; Charles S Craik
Journal:  Chem Rev       Date:  2014-10-02       Impact factor: 60.622

2.  TAOK3 phosphorylates the methylenecyclopropane nucleoside MBX 2168 to its monophosphate.

Authors:  Gloria Komazin-Meredith; Steven C Cardinale; Katelyn Comeau; Kevin J Magalhaes; Caroll B Hartline; John D Williams; Timothy J Opperman; Mark N Prichard; Terry L Bowlin
Journal:  Antiviral Res       Date:  2015-04-07       Impact factor: 5.970

Review 3.  Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance.

Authors:  Sunwen Chou
Journal:  Antiviral Res       Date:  2020-01-12       Impact factor: 5.970

4.  Opposite effects of cytomegalovirus UL54 exonuclease domain mutations on acyclovir and cidofovir susceptibility.

Authors:  Sunwen Chou
Journal:  Antiviral Res       Date:  2021-09-21       Impact factor: 5.970

Review 5.  Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes.

Authors:  Gail E Reid; Joseph P Lynch; Samuel Weigt; David Sayah; John A Belperio; Shellee A Grim; Nina M Clark
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.